Navigation Links
The Rudd Report, Dated April 18, 2008, Updates AMDL's Recent Achievements
Date:4/25/2008

TUSTIN, Calif., April 25 /PRNewswire-FirstCall/ -- AMDL, Inc. (Amex: ADL), an international biopharma company with development and manufacture of proprietary pharmaceutical and diagnostic products in China, announced today that a 4th Quarter Update and Year End Report on AMDL has been posted by analyst Lauren Rudd at (http://www.RuddReport.com). It includes a 12 month target price of $23 and a Buy Recommendation.

The Report highlights AMDL's recent and anticipated company goals and objectives in regards to DR-70(TM), Human Papilloma Virus (HPV), Jade Pharmaceutical Inc. 2008 business expansion and JPGreen Health & Beauty Clinics. It also covers various Peer Group Comparison & Valuation Analysis and their views and opinions on financial performance for FY2008.

The 21-page report goes into significant detail about AMDL's products, particularly AMDL's recent announcement in April 2008 that it has entered into an exclusive sublicense agreement for a diagnostic product for in-vitro genotype testing in women with Human Papilloma Virus (HPV), a potential billion dollar market.

"AMDL has had another profitable quarter, making it two in a row, a trend we feel goes a long way towards reaffirming our current projections that by the end of 2008, revenues from Jade alone will reach or exceed $38 million," Mr. Rudd writes.

About Jade Pharmaceutical Inc.: Jade has access to the fastest growing pharmaceutical and consumer market in the world: China. AMDL, through its subsidiary, Jade currently manufactures large volume injectable fluids, tablets and other related products, holding licenses for 133 products. It also manufactures 107 generic, over the counter and supplemental pharmaceutical products under certified Chinese Good Manufacturing Practice (CGMP) standards.

About AMDL: More information about AMDL and its products can be obtained at http://www.amdl.com.

Forward-Looking Statements: This news release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements are subject to certain risks and uncertainties, and actual circumstances, events or results may differ materially from those projected in such forward-looking statements. The Company cautions readers not to place undue reliance on any forward-looking statements. The Company does not undertake, and specifically disclaims any obligation, to update or revise such statements to reflect new circumstances or unanticipated events as they occur.

Disclaimer by Rudd

This disclaimer is an integral part of Rudd's service. Please read it before investing in any security on which we report.

Opinions are solely those of the staff of The Rudd Report and are subject to change without notice. Our reports are for information only and we do not offer securities or solicit the offer of securities of any company. Our reports are to inform the public and not to promote any company or its securities.

We do not inform any company in advance of the nature or conclusions of our reports nor can a company change what we write.

In the case of AMDL we received a fee for coverage of the current quarter in the amount of $6,000.

Our reports contain factual statements and opinions. We derive these factual statements from sources that we believe are accurate. However, we do not represent that the facts presented are accurate or complete. Furthermore, the information contained in this report may become inaccurate because of the passage of time and should therefore be read for historical information only.

Contact: AMDL, Inc.

Mr. Paul Knopick

AMDL Investor Relations

Direct Line: 949.707.5365

Voice Mail: 714.505.4460


'/>"/>
SOURCE AMDL, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Gateway Health Plan Ranked Again Among Americas Best Health Plans According to U.S. News & World Report, NCQA
2. U.S.News & World Report, NCQA Release Annual Rankings for Americas Best Health Plans
3. Academy of General Dentistry Releases Updated Employment Statistical Map
4. American Media, Inc. Provides Lenders With Updated Information
5. Hillenbrand Releases Investor Roadshow Materials and Updated Financial Guidance Related to Separation Of Hill-Rom and Batesville Casket
6. Health groups issue updated colorectal cancer screening guidelines
7. UPDATED: Catholic Healthcare West and SEIU Begin Negotiations for 15,000 Hospital Workers
8. Alliance for Quality Nursing Home Care Praises CMS Release of Updated Special Focus Facilities (SFF) List
9. Consumer Group Finds Use of Outdated Data and Other Major Flaws in Economists Defense of Mandatory Purchase of Private Health Insurance
10. Triple-S Management Corporation Reports Record Consolidated Operating Income, Net Income and EPS for 2007
11. CAHI Releases Updated Health Insurance Mandates in the States
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... ... October 13, 2017 , ... PurhealthRX , a leading Health and Nutrition ... the Purzorb™process to full spectrum CBD oil will revolutionize the rapidly growing CBD market ... can be easily incorporated into liquid products, while reducing costs to end users. , ...
(Date:10/13/2017)... , ... October 13, 2017 , ... The Visiting Nurse ... Market. Featuring a collection of specialty vendors and unique items from across the nation, ... quality-focused health and wellness services offered by the VNA. The boutique will be ...
(Date:10/13/2017)... (PRWEB) , ... October 13, 2017 , ... ... DevOps and Agile Software Development, has been awarded a contract by the Center ... Purchase Agreement (BPA) aims to accelerate the enterprise use of Agile methodologies in ...
(Date:10/12/2017)... ... ... Planet Fitness, one of the largest and fastest growing franchisors and operators ... location in Covington, LA at 401 N. U.S. Highway 190, in January of 2018. ... in the Holiday Square shopping center. Its location allows it to serve both Covington ...
(Date:10/12/2017)... ... October 12, 2017 , ... Information about the technology: ... develop to enable prevention of a major side effect of chemotherapy in children. ... pediatric patients. For cisplatin, hearing loss is FDA listed on-label as a dose ...
Breaking Medicine News(10 mins):
(Date:10/12/2017)... , Oct. 12, 2017 AVACEN Medical , ... company with their  2017 New Product Innovation Award for ... extensive primary and secondary medical device market research by Frost ... its first-to-market OTC, drug-free pain relief product, the AVACEN 100, ... to treating fibromyalgia widespread pain. ...
(Date:10/11/2017)...  Caris Life Sciences ® , a leading innovator ... precision medicine, today announced that St. Jude Medical Center,s ... (POA) as its 17 th member. Through participation ... Cancer Institute will help develop standards of care and ... making cancer treatment more precise and effective. ...
(Date:10/10/2017)... EXTON, Pa. , Oct. 10, 2017   ... leader in innovative solutions for injectable drug administration, today ... of West,s ID Adapter for improving the intradermal administration ... the Fourth Skin Vaccination Summit in May 2017 by ... Team Lead, Polio Department, World Health Organization (WHO), and ...
Breaking Medicine Technology: